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                                                            ABSTRACT 
INTRODUCTION 
Ischaemic heart disease has been regarded as one of the most common causes of hospital 
admission and mortality worldwide. In Africa, it has been estimated as the eighth most 
common cause of death, a continent that was previously said to have immunity from the 
disease. In order to make an informed decision with regard to the appropriate and necessary 
therapy for patients presenting with acute coronary syndrome (ACS), an assessment of 
common and easily identifiable poor prognostic factors of the disease is advocated. Studies 
done mostly outside Africa have identified the clinical parameters such as: increased heart 
rate and lower systolic blood pressure on admission among others as poor prognostic factors 
of mortality among patients admitted with ACS. This study aimed to determine the 
relationship of SBP on admission, clinical characteristics and mortality among patients 
admitted with ACS at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH).  
METHODS 
Patients aged 18 years and above admitted at the Cardiology Division CMJAH, with the 
diagnosis of ACS between the period of January 2010 and December 2012 were recruited for 
this study. All data with regard to clinical characteristics, investigations, medical as well as 
interventional therapies done to the patients were obtained from the database unit of the 
Cardiology Division. Those patients with missing information from the database had their 
record retrieved from the main Records department of the hospital. Patients were classified 
into 4 quartiles based on admitting systolic blood pressure (SBP) as follows: SBP 
<100mmHg, SBP 100-129mmHg (Normal), SBP 130-139 mmHg (pre-hypertension) and 
SBP ≥140mmHg (hypertension). 
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RESULTS 
 A total of 658 consecutive patients with the diagnosis of ACS admitted to the cardiology 
division of CMJAH were recruited during the two-and-half year study period with a 
prevalence of 21.8%. However, only 613 patients had completed data retrieved from their 
records and were used for this study. The patients consisted of 451 males (73.6%) and 162 
females (26.4%), with male-to-female ratio of 2.8:1. The mean age of patients in this study 
was 58.88 ±12.52, with the mean age of 57.39±11.96 and 63.01±12.62 for male and female 
respectively. Females were significantly older than males in this study (p <0.0001). Four 
racial groups consisting of Black, Coloured, White and Indian were identified from the study. 
The White group dominated the racial groups with 334 patients (55%) followed by Black 
group with 134 patients (22%). 
Patients who presented with higher SBP on admission were more likely to be smokers, 
hypertensives and had higher serum lipid.  Those with SBP <100mmHg had significantly 
higher frequency of Killip class ≥3 and higher mean heart rate. Admitting SBP was not 
significantly different among the 4 racial groups, gender and presenting age.  
Of the 613 patients, 27 died, contributing a mortality rate of 4.4%. After multiple logistic 
regression analysis, patients with SBP ≤100mmHg and those >65years of age had more than 
2/double the times risk of death compared to others. The risk of death was more than 4 to 5 
fold higher among those with Killip class 3-4 and those in atrial fibrillation (AF) respectively. 
Those with heart rate (HR) ≥96bpm and Haemoglobin (Hb) level of <11.4mg/dl had more 
than 2 and 4 times risk of death respectively. On the other hand, those that received higher 
number of drugs, with a proven medical benefit (Optimal medical therapy) had a better 
chance of survival compared to those who did not receive such optimal medical therapy.  
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CONCLUSION 
In this study, there were more male than female, with females being significantly older. 
Patients who presented with lower SBP levels were more likely to be in higher Killip class 
and had higher mean heart rate, while those with higher SBP levels were more likely to be 
hypertensives, smokers and had higher serum lipid levels. Lower SBP, advanced age, higher 
Killip class, AF, higher HR and lower Hb level were found to be positive predictors of 
mortality, while optimal medical therapy was positive predictor of survival.  
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